Kelly-Gemmell Dorothy Elizabeth bought VKTX
August 1, 2026 · Form 4 insider transaction
Kelly-Gemmell Dorothy Elizabeth bought 6,333 shares of Viking Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 6 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,333
Price
$0.00
Total value
N/A
RoleDirector
SecurityCommon Stock, par value $0.00001 per share
Transaction codeA: Grant or award
Transaction dateAugust 1, 2026
Filing dateAugust 7, 2026
Shares owned after6,333
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a restricted stock unit award ("RSU") of common stock under the Issuer's 2024 Equity Incentive Plan. One-third of the shares subject to the RSU shall vest on each one year anniversary of the grant date of the award.